THREE-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL: LATE CLINICAL OUTCOMES WITH BIORESORBABLE COMPARED TO PERMANENT POLYMER EVEROLIMUS-ELUTING

被引：1
|
作者：
Kereiakes, Dean J. [1 ]
Meredith, Ian [1 ]
Windecker, Stephan [1 ]
Rodes-Cabau, Josep [1 ]
Lee, Tommy [1 ]
Reitman, Arthur [1 ]
Erglis, Andrejs [1 ]
Dorogy, Mark [1 ]
Bertolet, Barry [1 ]
Cannon, Louis [1 ]
Airaksinen, Juhani [1 ]
Siegel, Craig [1 ]
Christen, Thomas [1 ]
Allocco, Dominic [1 ]
Dawkins, Keith [1 ]
机构：
[1] Christ Hosp, Heart & Vasc Ctr, Lindner Res Ctr, Cincinnati, OH 45219 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2017年 / 69卷 / 11期
关键词：
D O I：
10.1016/S0735-1097(17)34359-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1135M-09
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [1] LATE CLINICAL OUTCOMES AFTER BIORESORBABLE OR PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: 2-YEAR RESULTS FROM THE EVOLVE II RANDOMIZED TRIAL
    Kereiakes, Dean J.
    Meredith, Ian
    Windecker, Stephan
    Kabour, Ameer
    Bouchard, Alain
    Kini, Annapoorna
    Janssens, Luc
    Foster, Michael
    Stoler, Robert
    Stuckey, Thomas
    Batchelor, Wayne
    Christen, Thomas
    Allocco, Dominic
    Dawkins, Keith
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 17 - 17
  • [2] Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
    Kerkmeijer, Laura S. M.
    Tijssen, Ruben Y. G.
    Hofma, Sjoerd H.
    van der Schaaf, Rene J.
    Arkenbout, Karin E.
    Kraak, Robin P.
    Weevers, Auke P. J. D.
    Piek, Jan J.
    de Winter, Robbert J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    Wykrzykowska, Joanna J.
    EUROINTERVENTION, 2019, 15 (07) : 603 - +
  • [3] Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial
    Serruys, Patrick
    Chevalier, Bernard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B27 - B27
  • [4] Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial
    Ribamar Costa, J., Jr.
    Abizaid, Alexandre
    Whitbourn, Robert
    Serruys, Patrick W.
    Jepson, Nigel
    Steinwender, Clemens
    Stuteville, Marrianne
    Ediebah, Divine
    Sudhir, Krishnankutty
    Bartorelli, Antonio L.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (01) : E1 - E7
  • [5] CLINICAL OUTCOMES TO 4 YEARS IN PATIENTS IMPLANTED WITH BIOABSORBABLE POLYMER SYNERGY VERSUS PERMANENT POLYMER EVEROLIMUS-ELUTING STENTS: THE EVOLVE II RANDOMIZED TRIAL
    Jobe, Robert
    Windecker, Stephan
    Loli, Akil
    Mego, David
    Ando, Kenji
    Muramatsu, Toshiya
    Stammen, Francis
    Curtis, Michael
    Helqvist, Steffen
    Christen, Thomas
    Allocco, Dominic
    Meredith, Ian
    Kereiakes, Dean
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1018 - 1018
  • [6] Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
    Xu, Bo
    Yang, Yuejin
    Han, Yaling
    Huo, Yong
    Wang, Lefeng
    Qi, Xiangqian
    Li, Jifu
    Chen, Yundai
    Kuo, Hai-Chien
    Ying, Shih-Wa
    Cheong, Wai-Fung
    Zhang, Yunlong
    Su, Xiaolu
    Popma, Jeffery J.
    Gao, Runlin
    Stone, Gregg W.
    EUROINTERVENTION, 2018, 14 (05) : 554 - 561
  • [7] Three-Year Results of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Infrapopliteal Arteries
    Varcoe, Ramon L.
    Thomas, Shannon D.
    Lennox, Andrew F.
    JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (06) : 694 - 701
  • [8] Three-Year Results of Safety and Efficacy of the Everolimus-Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)
    Ng, Vivian G.
    Lansky, Alexandra J.
    Hermiller, James B.
    Farhat, Naim
    Applegate, Robert J.
    Yaqub, Manejeh
    Sood, Poornima
    Su, Xiaolu
    Simonton, Charles A.
    Sudhir, Krishnankutty
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (06): : 841 - 848
  • [9] Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial
    Kerkmeijer, Laura S. M.
    Renkens, Mick P. L.
    Tijssen, Ruben Y. G.
    Hofma, Sjoerd H.
    van der Schaaf, Rene J.
    Arkenbout, E. Karin
    Weevers, Auke P. J. D.
    Garcia-Garcia, Hector M.
    Kraak, Robin
    Piek, Jan J.
    Tijssen, Jan G. P.
    Henriques, Jose P. S.
    de Winter, Robbert J.
    Wykrzykowska, Joanna J.
    EUROINTERVENTION, 2022, 17 (16) : 1340 - +
  • [10] Clinical Outcomes of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Final 5-Year Results From the ABSORB III Trial
    Ellis, Stephen
    Kereiakes, Dean
    Stone, Gregg
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B166 - B166
12345